Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Turk J Phys Med Rehabil ; 63(3): 239-248, 2017 Jun.
Article in English | MEDLINE | ID: mdl-31453460

ABSTRACT

OBJECTIVES: The primary aim of this study was to compare the effects of aquatic exercises and land-based exercises on spasticity, quality of life, and motor function in children with cerebral palsy (CP). The secondary aim was to assess the morphology of spastic muscle using ultrasonography. PATIENTS AND METHODS: Thirty-two children (17 boys, 15 girls; mean age 9.7±2.7 years; range 4 to 17 years) with CP were enrolled in this study. The patients were randomly assigned to two groups to receive 30 sessions of an aquatic or a land-based exercise program. The patients were assessed for the impairment level, functional measures, and quality of life before and after therapy. Ultrasonographic assessment of spastic gastrocnemius muscle was also performed. RESULTS: Both group showed significant improvements in most functional outcome measures. There were no significant differences in the percentage changes of the scores for functional outcome measures between the two groups. However, aquatic exercise produced a higher improvement in quality of life scores than the land-based exercises. Post-treatment ultrasonographic assessment of spastic gastrocnemius muscle showed a significant improvement in the compressibility ratio in the aquatic exercise group. The modified Ashworth Scale score of spastic gastrocnemius muscle in patients with CP showed a negative and weak-to-moderate correlation with the compressibility ratio based on the ultrasonographic evaluation. CONCLUSION: Our study results suggest that the aquatic exercises are as effective as land-based exercises for spasticity management and motor function improvement in children with CP. Aquatic exercise can result in a higher level of improvement in quality of life scores than the land- based exercises. Ultrasonographic muscle compressibility ratio may be used to evaluate muscle elasticity in children with CP.

2.
Clin Respir J ; 11(6): 743-750, 2017 Nov.
Article in English | MEDLINE | ID: mdl-26597394

ABSTRACT

INTRODUCTION: Serious problems on muscle strength and functional status can be seen in bedridden-patients with chronic obstructive pulmonary diseases (COPD) receiving mechanical ventilation. We aimed to investigate the impact of active extremity mobilization and neuromuscular electrical stimulation (NMES) on weaning processes, discharge from hospital and inflammatory mediators in COPD patients receiving mechanical ventilation. METHODS: Thirty conscious COPD patients (F/M:15/15) hospitalized in the intensive care unit (ICU) with diagnosis of respiratory failure were enrolled to this study. Patients were randomized into three groups, including 10 patients for each. Active extremity-exercise training and NMES were applied to Group-1, only NMES was applied to Group-2 and active extremity exercise training was applied to Group-3. Muscle strengths, mobilization duration and weaning situation were evaluated. Serum cytokine levels were evaluated. RESULTS: Lower extremity muscle-strength was significantly improved in Group-1 (from 3.00 to 5.00, P = 0.014) and 2 (from 4.00 to 5.00, P = 0.046). Upper extremity muscle strength was also significantly improved in all three groups (from 4.00 to 5.00 for all groups, P = 0.038, P = 0.046 and P = 0.034, respectively). Duration of mobilization and discharge from the ICU were similar among groups. There was a significant decrease in serum interleukin (IL)-6 level in Group-1 and in serum IL-8 level in Group-1 and Group-2 after rehabilitation. CONCLUSION: This study indicates that pulmonary rehabilitation can prevent loss of muscle strength in ICU. Nevertheless, we consider that further studies with larger populations are needed to examine the impact of NMES and/or active and passive muscle training in bedridden ICU patients who are mechanically ventilated.


Subject(s)
Electric Stimulation Therapy/methods , Intensive Care Units/standards , Muscle Weakness/prevention & control , Pulmonary Disease, Chronic Obstructive/therapy , Aged , Aged, 80 and over , Biomarkers/blood , Cytokines/blood , Exercise/physiology , Female , Humans , Interleukin-6/blood , Interleukin-8/blood , Length of Stay/statistics & numerical data , Male , Middle Aged , Muscle Strength/physiology , Muscle Weakness/rehabilitation , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/rehabilitation , Respiration, Artificial/adverse effects , Respiratory Insufficiency/diagnosis , Respiratory Insufficiency/therapy , Ventilator Weaning/standards
3.
J Rehabil Med ; 48(7): 604-8, 2016 Jul 18.
Article in English | MEDLINE | ID: mdl-27311844

ABSTRACT

OBJECTIVE: Early degeneration of the knees might occur in patients with multiple sclerosis secondary to balance and walking impairment and muscle weakness. The aims of this study were to evaluate the knee joints of patients with multiple sclerosis compared with healthy controls, using ultrasono-graphy, and to investigate whether there is any correlation between femoral cartilage degeneration and disease-related parameters. DESIGN: Study participants were 79 patients with multiple sclerosis and 60 healthy controls. The disease-related parameters, Expanded Disability Status Scale (EDSS), Western Ontario and McMaster Universities (WOMAC) osteoarthritis index, visual analogue scale (VAS) for pain severity, and Berg Balance Scale (BBS) scores were recorded. Femoral cartilage and knee effusion were evaluated using ultrasonography. RESULTS: Femoral cartilages of patients with multiple sclerosis were more degenerated than those of healthy controls. Moreover, patients with multiple sclerosis had more effusion in their knees than did controls. In the multiple sclerosis group there was no correlation between cartilage degeneration grade, amount of effusion, and VAS-pain, BBS, WOMAC and EDSS scores. CONCLUSION: Patients with multiple sclerosis may have more rapid degeneration of the knee cartilage and increased effusion compared with healthy controls. Ultrasonography is an effective method to detect these changes. However, cartilage degeneration was not found to be associated with disease-related parameters in multiple sclerosis.


Subject(s)
Multiple Sclerosis/complications , Osteoarthritis, Knee/diagnostic imaging , Ultrasonography , Adult , Aged , Cartilage/diagnostic imaging , Cartilage/pathology , Case-Control Studies , Female , Femur/diagnostic imaging , Humans , Knee Joint/diagnostic imaging , Knee Joint/pathology , Male , Middle Aged , Osteoarthritis, Knee/etiology , Osteoarthritis, Knee/pathology , Pain Measurement , Severity of Illness Index
4.
Int J Rheum Dis ; 19(3): 287-93, 2016 Mar.
Article in English | MEDLINE | ID: mdl-25955771

ABSTRACT

AIM: The use of biomarkers of osteoarthritis (OA) have potential for early diagnosis, evaluation of disease severity and monitoring treatment. Serum and synovial fluid YKL-40 levels are increased in severe knee OA. Pulsed electromagnetic field (PEMF) therapy is a novel treatment method for OA. However, studies evaluating the PEMF therapy in treatment of knee OA revealed conflicting results. This study was conducted to objectively assess the effect of PEMF therapy in patients with knee OA, by using ultrasonographic measurements and a novel biomarker, YKL-40. METHODS: Forty patients were randomized into two treatment groups. Both groups received conventional physical therapy, while Group 1 received additional PEMF therapy. The patients were asked to rate their pain on a visual analogue scale (VAS) and complete a Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire. Serum YKL-40 levels were measured, and knee effusion and cartilage degeneration level were evaluated with ultrasonography before and after treatment. RESULTS: Pre-treatment YKL-40 level was correlated with WOMAC pain subscale (P = 0.032, r = 0.339). VAS and WOMAC scores significantly improved in both treatment groups (P < 0.05). The effusion in the right knee significantly decreased in Group 1. The change in YKL-40 level was not correlated with the change in VAS, WOMAC scores and knee effusion. CONCLUSION: This study revealed that adjuvant PEMF therapy has no additional effect on pain in patients with knee OA. Serum YKL-40 level seems to be unuseful for monitoring the treatment in knee OA.


Subject(s)
Chitinase-3-Like Protein 1/blood , Electromagnetic Fields , Magnetic Field Therapy/methods , Osteoarthritis, Knee/therapy , Ultrasonography , Adult , Aged , Biomarkers/blood , Combined Modality Therapy , Electromagnetic Fields/adverse effects , Female , Humans , Magnetic Field Therapy/adverse effects , Male , Middle Aged , Osteoarthritis, Knee/blood , Osteoarthritis, Knee/diagnostic imaging , Pain Measurement , Physical Therapy Modalities , Predictive Value of Tests , Surveys and Questionnaires , Time Factors , Treatment Outcome , Turkey
5.
Rheumatol Int ; 36(1): 17-23, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26186891

ABSTRACT

Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown origin. The aim of this study is to clarify the relationships between susceptibility and severity of AS and GST-mu1 (GSTM1), GST-theta1 (GSTT1), GST-pi1 (GSTP1)-Ile105Val and angiotensin-converting enzyme (ACE) I/D polymorphisms in AS patients. One hundred thirty-eight AS patients and seventy-one healthy controls were enrolled in this study. Erythrocyte sedimentation rate and C-reactive protein (CRP) levels of the AS patients were recorded. The scores of the numeric rating scale (NRS) pain, the Bath Ankylosing Spondylitis Activity Index, the Bath Ankylosing Spondylitis Metrology Index and the Bath Ankylosing Spondylitis Functional Index were calculated. The genotypes distributions and allele frequencies of GSTM1, GSTT1, GSTP1-Ile105Val and ACE I/D polymorphisms were compared between patients and healthy controls. The Multiplex polymerase chain reaction (PCR) and the PCR-restriction fragment length polymorphism methods were used to detect the polymorphisms of ACE I/D, the GSTT1 and GSTM1 genes and the GSTP1-Ile105Val polymorphism, respectively. There were significantly higher levels of the GSTT1 null and the ACE II genotypes in AS patients compared to those in healthy controls (p = 0.002 and 0.005, respectively). We found significantly higher levels of CRP and the NRS pain scores in the patients with ACE ID or DD genotypes compared to those in the patients with ACE II genotypes (p = 0.005 and 0.035, respectively). The present results showed that genes involved in protection from oxidative stress and ACE gene may influence disease development and course in AS.


Subject(s)
Glutathione S-Transferase pi/genetics , Glutathione Transferase/genetics , Peptidyl-Dipeptidase A/genetics , Spondylitis, Ankylosing/genetics , Adult , Alleles , C-Reactive Protein/metabolism , Case-Control Studies , Female , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Genotype , Humans , Male , Middle Aged , Oxidative Stress/genetics , Polymorphism, Single Nucleotide , Spondylitis, Ankylosing/blood
6.
Clinics (Sao Paulo) ; 70(4): 296-300, 2015 Apr.
Article in English | MEDLINE | ID: mdl-26017798

ABSTRACT

OBJECTIVE: Fibromyalgia is characterized by diffuse musculoskeletal pain and discomfort. There are several reports regarding autonomic nervous system dysfunction in patients with fibromyalgia. Heart rate turbulence is expressed as ventriculophasic sinus arrhythmia and has been considered to reflect cardiac autonomic activity. Heart rate turbulence has been shown to be an independent and powerful predictor of sudden cardiac death in various cardiac abnormalities. The aim of this study is to determine whether heart rate turbulence is changed in female patients with fibromyalgia compared with healthy controls. METHODS: Thirty-seven female patients (mean age, 40±11 years) with fibromyalgia, and 35 age- and sex-matched healthy female control subjects (mean age, 42±9 years) were included. Twenty-four hours of ambulatory electrocardiography recordings were collected for all subjects, and turbulence onset and turbulence slope values were automatically calculated. RESULTS: The baseline clinical characteristics of the two groups were similar. There were no significant differences in turbulence onset and turbulence slope measures between patients and control subjects (turbulence onset: -1.648±1.568% vs. -1.582±1.436%, p ϝ 0.853; turbulence slope: 12.933±5.693 ms/RR vs. 13.639±2.505 ms/RR, p ϝ 0.508). Although body mass index was negatively correlated with turbulence slope (r ϝ -0.258, p ϝ 0.046), no significant correlation was found between body mass index and turbulence onset (r ϝ 0.228, p ϝ 0.054). CONCLUSION: To the best of our knowledge, this is the first study to evaluate heart rate turbulence in patients with fibromyalgia. It appears that heart rate turbulence parameters reflecting cardiac autonomic activity are not changed in female patients with fibromyalgia.


Subject(s)
Arrhythmia, Sinus/physiopathology , Fibromyalgia/physiopathology , Heart Rate/physiology , Adult , Autonomic Nervous System/physiopathology , Blood Pressure/physiology , Body Mass Index , Case-Control Studies , Electrocardiography, Ambulatory , Female , Humans , Middle Aged , Risk Factors
7.
Clinics ; 70(4): 296-300, 04/2015. tab, graf
Article in English | LILACS | ID: lil-747114

ABSTRACT

OBJECTIVE: Fibromyalgia is characterized by diffuse musculoskeletal pain and discomfort. There are several reports regarding autonomic nervous system dysfunction in patients with fibromyalgia. Heart rate turbulence is expressed as ventriculophasic sinus arrhythmia and has been considered to reflect cardiac autonomic activity. Heart rate turbulence has been shown to be an independent and powerful predictor of sudden cardiac death in various cardiac abnormalities. The aim of this study is to determine whether heart rate turbulence is changed in female patients with fibromyalgia compared with healthy controls. METHODS: Thirty-seven female patients (mean age, 40±11 years) with fibromyalgia, and 35 age- and sex-matched healthy female control subjects (mean age, 42±9 years) were included. Twenty-four hours of ambulatory electrocardiography recordings were collected for all subjects, and turbulence onset and turbulence slope values were automatically calculated. RESULTS: The baseline clinical characteristics of the two groups were similar. There were no significant differences in turbulence onset and turbulence slope measures between patients and control subjects (turbulence onset: −1.648±1.568% vs. −1.582±1.436%, p ϝ 0.853; turbulence slope: 12.933±5.693 ms/RR vs. 13.639±2.505 ms/RR, p ϝ 0.508). Although body mass index was negatively correlated with turbulence slope (r ϝ −0.258, p ϝ 0.046), no significant correlation was found between body mass index and turbulence onset (r ϝ 0.228, p ϝ 0.054). CONCLUSION: To the best of our knowledge, this is the first study to evaluate heart rate turbulence in patients with fibromyalgia. It appears that heart rate turbulence parameters reflecting cardiac autonomic activity are not changed in female patients with fibromyalgia. .


Subject(s)
Humans , Male , Middle Aged , Embolization, Therapeutic , Head and Neck Neoplasms/blood supply , Head and Neck Neoplasms/diagnosis , Hemangiopericytoma/blood supply , Hemangiopericytoma/diagnosis , Image Enhancement , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Neovascularization, Pathologic/diagnosis , Preoperative Care , Blood Vessels/pathology , Diagnosis, Differential , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/surgery , Hemangiopericytoma/pathology , Hemangiopericytoma/surgery , Neovascularization, Pathologic/pathology , Neovascularization, Pathologic/surgery
8.
Lasers Med Sci ; 30(3): 1097-107, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25614134

ABSTRACT

Lateral epicondylitis (LE) is a common disorder that causes pain on the outside of the elbow, as well as pain and weakness during gripping. In this prospective, randomized, controlled, assessor-blinded trial, we planned to investigate the effects of high-intensity laser therapy (HILT) in patients with LE and to compare these results with those of a brace and placebo HILT. Patients were randomly assigned to three treatment groups. The first group was treated with HILT. The second group (sham therapy group) received placebo HILT, while the third group (brace group) used the lateral counterforce brace for LE. The patients were assessed for grip strength, pain, disability, and quality of life. Outcome measurements and ultrasonographic examination of the patients were performed before treatment (week 0) and after treatment (after 4 and 12 weeks). HILT and brace groups showed significant improvements for most evaluation parameters (pain scores, grip strength, disability scores, and several subparts of the short-form 36 health survey (physical function, role limitations due to physical functioning, bodily pain, general health, and vitality)) after treatment (after 4 and 12 weeks). However, the improvements in evaluation parameters of the patients with LE in HILT and brace groups were not reflected to ultrasonographic findings. Furthermore, comparison of the percentage changes of the parameters after treatment relative to pretreatment values did not show a significant difference between HILT and brace groups. We conclude that HILT and splinting are effective physical therapy modalities for patients with LE in reducing pain and improving disability, quality of life, and grip strength.


Subject(s)
Laser Therapy , Tennis Elbow/surgery , Adult , Female , Hand Strength , Humans , Male , Pain , Pain Measurement , Prospective Studies , Quality of Life , Single-Blind Method , Splints , Treatment Outcome , Young Adult
9.
Lasers Med Sci ; 30(1): 325-32, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25274197

ABSTRACT

Myofascial pain syndrome (MPS) of the trapezius muscle is one of the main causes of neck pain. In this randomized, double-blind study, we evaluated the effects of high-intensity laser therapy (HILT) in female patients with chronic MPS of the trapezius muscle. The patients were assigned to two groups. The HILT group was treated with HILT and exercise, and the sham therapy group was treated with placebo HILT and exercise. The patients were assessed for pain, cervical active range of motion, disability, and quality of life. Evaluations were performed before treatment (week 0) and after treatment (weeks 4 and 12). Both groups showed significant improvement in all parameters at weeks 4 and 12. However, in a comparison of the percentage changes in the parameters at weeks 4 and 12 relative to pretreatment values, the HILT group showed greater improvement in pain scores, the neck disability index, and several subparts of the short-form 36 health survey (SF-36) (physical functioning, role limitations due to physical functioning, bodily pain, general health perceptions, social functioning, and role limitations due to emotional problems) than did the sham therapy group. We conclude that HILT is an effective therapeutic method in the treatment of patients with chronic MPS of the trapezius muscle.


Subject(s)
Laser Therapy , Lasers, Solid-State/therapeutic use , Myofascial Pain Syndromes/surgery , Superficial Back Muscles/surgery , Adult , Double-Blind Method , Female , Humans , Middle Aged , Pain Measurement , Quality of Life , Treatment Outcome , Young Adult
10.
Mod Rheumatol ; 25(1): 128-33, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25036227

ABSTRACT

OBJECTIVE: The aim of this study was to assess the ultrasonographic (US) findings of pes anserinus tendon and bursa in patients with knee osteoarthritis (OA) with or without clinical pes anserinus tendinitis bursitis syndrome (PATBS). METHODS: A total of 157 female patients with the diagnosis of knee OA on both knees (314 knees), and 30 age, and body mass index- matched healthy female controls without knee pain (60 knees), were included in the study. PATBS was clinically diagnosed. US evaluation parameters were the measurement of the thickness of pes anserinus tendon insertion region (PA) and examination of the morphologic intratendinous PA tissue characteristics and pes anserinus bursitis (PAB). Radiographic knee osteoarthritis graded I-IV according to Kellgren and Lawrence (KL) for each knee was recorded. Pain and functional status were assessed by the Visual Analog Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). RESULTS: There were 183 PATBS (58.3%) clinical diagnoses among the 314 knees with OA. The mean thickness of PA in the patients with knee OA graded 1,2,3,4 with/without PATBS was significantly greater than the controls (p = 0.001). The mean thickness of PA in knees with OA KL graded 3 and 4 with/without PATBS, was greater than knees with OA KL graded 1 and 2 with/without PATBS (p < 0,05) (except knee OA KL graded 2 with PATBS versus knee OA KL graded 4 without PATBS).The knee OA KL graded 1,2,3,4 with PATBS had significantly more PAB and less loss of normal fibrillar echotexture of PA compared to controls and knees with OA KL graded 1,2,3,4 without PATBS (p < 0.05). The VAS scores of knees with OA KL graded 3, 4 with PATBS were significantly greater than those of knees with OA KL graded 3,4 without PATBS (p < 0.05). PA thickness was significantly associated with the KL grade (r: 0.336, p:0.001) and PATBS (r: 0.371, p < 0.001). CONCLUSION: It is concluded that the mean thickness of PA in knees with OA with/without PATBS was significantly greater than the controls. The mean thickness of PA in knees with OA, KL graded 3 and 4 with/without PATBS, was greater than in knees with OA KL graded 1 and 2 with/without PATBS. The knee OA with PATBS had significantly more PAB, less loss of normal fibrillar echotexture of PA, and higher VAS scores compared to the knees with OA without PATBS. US can serve as a useful diagnostic tool for detection of PATBS in knee OA.


Subject(s)
Bursitis/diagnostic imaging , Knee Joint/diagnostic imaging , Osteoarthritis, Knee/diagnostic imaging , Tendinopathy/diagnostic imaging , Tendons/diagnostic imaging , Adult , Aged , Body Mass Index , Bursitis/complications , Female , Humans , Middle Aged , Osteoarthritis, Knee/complications , Pain Measurement , Tendinopathy/complications , Ultrasonography
12.
Rheumatol Int ; 34(9): 1257-61, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24671502

ABSTRACT

Fibromyalgia may present with widespread pain and tenderness, fatigue, anxiety, and depression and is associated with a low pain threshold. The etiology of fibromyalgia is yet to be ascertained, although both genetic and environmental factors may play a role in the susceptibility of patients to fibromyalgia. Various genetic variations have been investigated to explain fibromyalgia susceptibility and differences in pain sensitivity, pain threshold, and tolerance. The A118G rs1799971 polymorphism in the opioid receptor µ1 gene (OPRM1) is one of the candidate genes. We hypothesized that the OPRM1 polymorphism may play a role in fibromyalgia susceptibility and impact the pain intensity and pain-related symptoms in fibromyalgia patients. This study comprised of 108 patients with fibromyalgia and 100 healthy controls. Overall, the 118G allele frequency was 16.3 % and was significantly lower in patients with fibromyalgia than in the control group (13.9 and 19 %, respectively). No difference was observed between fibromyalgia patients with and without the A118G allele with regard to the Beck Depression Inventory, widespread pain index, symptom severity, and Fibromyalgia Impact Questionnaire scores. All body parts of patients with fibromyalgia demonstrated lower pressure pain thresholds (PPT) compared to controls. The PPTs were higher in the 118 A/A genotype carrier fibromyalgia patients than in 118*/G carriers; however, the differences were not significant. As the A118G polymorphism frequency was lower in fibromyalgia patients, this polymorphism may exert a protective effect against fibromyalgia in Turkish women. However, the OPRM1 polymorphism does not have a significant effect on pressure pain and fibromyalgia severity.


Subject(s)
Fibromyalgia/genetics , Pain/genetics , Polymorphism, Genetic , Receptors, Opioid, mu/genetics , Adult , Case-Control Studies , Female , Fibromyalgia/diagnosis , Fibromyalgia/epidemiology , Fibromyalgia/physiopathology , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Humans , Pain/diagnosis , Pain/epidemiology , Pain/physiopathology , Pain Measurement , Pain Threshold , Phenotype , Predictive Value of Tests , Protective Factors , Risk Factors , Severity of Illness Index , Sex Factors , Turkey/epidemiology
13.
PM R ; 6(6): 564-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24412636

ABSTRACT

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease characterized by demyelination of the peripheral and central nerves. Patients with MLD can present with gait disturbances, progressive spastic quadriparesis, diffuse muscle atrophy, and areflexia attributable to central or peripheral nerve involvements. The rehabilitation of patients with MLD generally focuses on gait disturbances, balance impairments, and muscle weaknesses. Here, we present a case of MLD in which virtual reality (VR) training was used as an adjunctive therapy. We also discuss the complementary role of VR therapy, which was successfully integrated with a conventional rehabilitation program for a young patient with MLD who had impaired balance and gait. After completion of the integrated rehabilitation program, the patient demonstrated improvements in functional independency, mobility, walking speed, and balance. His total Functional Independence Measure score increased from 97 to 109, 6-minute walk test increased from 342 to 396 m, 10-minute walk test decreased from 11 to 7 seconds, and Berg Balance Scale score increased from 38 to 42 points. Moreover, 6 weeks after completion of the therapy, these improvements were sustained for the most part. Adding VR to a conventional rehabilitation program is an emerging trend in neurologic rehabilitation. Our patient with MLD demonstrated considerable improvements with a high level of enjoyment and satisfaction.


Subject(s)
Leukodystrophy, Metachromatic/rehabilitation , Postural Balance/physiology , Virtual Reality Exposure Therapy/methods , Follow-Up Studies , Gait/physiology , Humans , Leukodystrophy, Metachromatic/diagnosis , Male , Severity of Illness Index , Task Performance and Analysis , Treatment Outcome , Young Adult
14.
Turk Pediatri Ars ; 49(1): 77-80, 2014 Mar.
Article in English | MEDLINE | ID: mdl-26078637

ABSTRACT

Complex regional pain syndrome type 1 is one of the causes of morbidity of childhood which is also named reflex symphathetic dystrophia. The syndrome is characterized with regional pain and vasomotor, sudomotor and sensory changes in the distal parts of the extremities involved. Complex regional pain syndrome type 1 shows difference in children in terms of clinical picture and imaging methods compared to adults. The most important point is that the prognosis is generally better in children if early diagnosis and treatment is provided. On the other hand, causes including presence of psychological factors or less contribution of imaging methods in children lead to delayed diagnosis or erroneous diagnosis. In this article, a 10 year-old male patient who was diagnosed with complex regional pain syndrome type 1 was described. Thus, we aimed to remind clinicians that this syndrome should also be kept in mind in the differential diagnosis of pain in children.

15.
Balkan Med J ; 30(3): 277-81, 2013 Sep.
Article in English | MEDLINE | ID: mdl-25207119

ABSTRACT

BACKGROUND: The most commonly observed pathology in chest traumas is rib fracture, and the most important clinical symptom is severe pain. AIMS: To investigate the effectiveness of intramuscular opioid (IMO), intravenous patient-controlled analgesia (IVPCA) and the Fentanyl transdermal therapeutic system (TTS) in the management of rib fracture pain. STUDY DESIGN: Prospective randomized clinical trial. METHODS: In our prospective and randomised study, we included 45 patients with a diagnosis of multiple rib fractures. There were three groups and intercostal nerve blockage (ICB) in the first day and oral paracetamol for five days was administered to each group as standard. In Group IMO (n=15), 4×40 mg pethidine HCl was administered to the patients, while in Group IVPCA (n=15) this was 5 µg/mL continuous intravenous fentanyl and was 50 µg fentanyl TTS in Group TTS (n=15). The demographics, injury data and vital signs of the patients were recorded. Pain was scored using Visual Analogue Scale (VAS). The pain during lying down (VASl) and mobilisation (VASm) was detected. RESULTS: There were no differences between the three groups regarding age, sex, the trauma pattern, the number and distribution of costal fracture localisations, the presence of additional pathology, complications, thoracal catheter and the duration of thoracal catheter. No significant difference between the groups regarding systolic and diastolic arterial tension, number of breaths and beats in a minute was observed (p>0.05). We observed an improvement in the mean VAS score after treatment in all three groups. The mean VASl score significantly decreased after treatment in each group (p<0.05). The mean VASl and VASm scores measured on the 1(st), 2(nd), 3(rd), 4(th) and 5(th) days were found to be higher in Group IMO than in Groups IVPCA and TTS; however, these differences were not statistically significant (p>0.05). CONCLUSION: In the analgesia of patients with multiple rib fractures, TTS administration with ICB showed similar effectiveness with IVPCA administration with ICB. In the management of pain due to multiple rib fractures, TTS administration is a safe, non-invasive and effective procedure.

16.
J Back Musculoskelet Rehabil ; 22(4): 223-5, 2009.
Article in English | MEDLINE | ID: mdl-20023354

ABSTRACT

PURPOSE: The shoulder complex plays an integral role in the activities of daily living and the limitation of its function can greatly affect the patient. The aim of this study was to research the functional consequences of painful conditions in the shoulder region. METHODS: Sixty five adult patients with shoulder pain for longer than one month in duration were included to the study. Dominant hands of the patients were determined. The subjects were divided into two groups: shoulder pain at the dominant upper extremity (Group I) or the nondominant one (Group II). The subjects were evaluated for shoulder pain with visual analog scale (VAS), range of motion and functional status with the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. RESULTS: In Group I, DASH score was significantly correlated with the VAS score measuring the pain during activity (p< 0.0001, r=0,625). In Group II, no relationship between DASH score, VAS scores and any other parameters was detected. CONCLUSION: The most important parameter disturbing the daily living of a patient with shoulder disease is the pain at the shoulder of dominant extremity occurring in active movement.


Subject(s)
Activities of Daily Living/psychology , Functional Laterality/physiology , Shoulder Pain/physiopathology , Shoulder Pain/psychology , Adult , Aged , Aged, 80 and over , Disability Evaluation , Health Surveys , Humans , Middle Aged , Pain Measurement , Range of Motion, Articular/physiology , Shoulder Joint/physiopathology
17.
Heart Surg Forum ; 12(5): E266-71, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19833593

ABSTRACT

OBJECTIVE: We compared the effectiveness of continuous transcutaneous electrical nerve stimulation (TENS) and intermittent TENS in the management of pain after coronary artery bypass grafting (CABG). METHODS: We randomized 100 patients who had undergone median sternotomy for CABG into 4 groups with 25 patients each: (1) continuous TENS (CTENS) and pharmacologic analgesia, (2) intermittent TENS (ITENS) and pharmacologic analgesia, (3) placebo TENS (PTENS) and pharmacologic analgesia, and (4) pharmacologic analgesia alone (control). We studied these groups with regard to the relief of postoperative pain during the first 24 hours. For each patient we recorded the following: demographic characteristics; vital signs; intensity of pain with a visual analogue scale (VAS) before treatment (VAS(0)), at the 12th hour (VAS(12)), and at the 24th hour (VAS(24)); and analgesic intake. RESULTS: The groups were comparable with respect to age, sex, and body mass index at baseline. Mean VAS scores decreased within each group; however, the mean VAS(12) and VAS(24) scores decreased significantly in the CTENS and ITENS groups, compared with PTENS and control groups (P < .05). We found no significant difference between the CTENS and ITENS groups with respect to decreasing VAS(12) and VAS(24) scores (P > .05). Narcotic intake was significantly less in the CTENS and ITENS groups than in the control and PTENS groups (P < .01). Furthermore, narcotic requirements were significantly lower in the CTENS group than in the ITENS group (P < .01). CONCLUSIONS: CTENS and ITENS after median sternotomy for CABG decreased pain and reduced narcotic requirements more than in the PTENS and control treatments during first postoperative 24 hours. Neither CTENS nor ITENS is superior to the other in decreasing pain; however, CTENS leads to a greater reduction in the narcotic requirement than ITENS.


Subject(s)
Coronary Artery Bypass , Pain, Postoperative/therapy , Transcutaneous Electric Nerve Stimulation/methods , Aged , Analgesia, Patient-Controlled , Analgesics, Opioid/administration & dosage , Carbon Dioxide/blood , Female , Forced Expiratory Volume/drug effects , Humans , Male , Middle Aged , Morphine/administration & dosage , Oxygen/blood , Pain Measurement , Pain, Postoperative/diagnosis , Vital Capacity/drug effects
18.
Spine (Phila Pa 1976) ; 34(14): 1436-40, 2009 Jun 15.
Article in English | MEDLINE | ID: mdl-19525833

ABSTRACT

STUDY DESIGN: This study was a prospective, randomized, controlled study. OBJECTIVE: To compare the effectiveness of aquatic exercise interventions with land-based exercises in the treatment of chronic low back pain (CLBP). SUMMARY OF BACKGROUND DATA: Land-based exercise and physiotherapy are the main treatment tools used for CLBP. Clinical experience indicates that aquatic exercise may have advantages for patients with musculoskeletal disorders. METHODS: A total of 65 patients with CLBP were included in this study. Patients were randomly assigned to receive aquatic exercise or land-based exercise treatment protocol. Aquatic exercise program consisted of 20 sessions, 5 x per week for 4 weeks in a swimming pool at 33 degrees C. Land-based exercise (home-based exercise) program were demonstrated by a physiotherapist on one occasion and then they were given written advice The patients were assessed for spinal mobility, pain, disability, and quality of life. Evaluations were performed before treatment (week 0) and after treatment (week 4 and week 12). RESULTS: In both groups, statistically significant improvements were detected in all outcome measures (except modified Schober test) compared with baseline. However, improvement in modified Oswestry Low Back Pain Disability questionnaire and physical function and role limitations due to physical functioning subpart of Short-Form 36 Health Survey were better in aquatic exercise group (P < 0.05). CONCLUSION: It is concluded that a water-based exercises produced better improvement in disability and quality of life of the patients with CLBP than land-based exercise.


Subject(s)
Exercise Therapy/methods , Exercise/physiology , Low Back Pain/therapy , Swimming/physiology , Adult , Chronic Disease , Disability Evaluation , Female , Humans , Low Back Pain/physiopathology , Male , Pain Measurement/methods , Spine/physiopathology , Surveys and Questionnaires , Time Factors , Treatment Outcome
19.
J Bone Miner Metab ; 27(4): 464-70, 2009.
Article in English | MEDLINE | ID: mdl-19301089

ABSTRACT

There is much evidence suggesting that the decline in ovarian function after menopause is associated with spontaneous increases in proinflammatory cytokines. Treatment with risedronate is accompanied by significant changes in bone turnover and bone mineral density. The objective of this study was to determine the effects of risedronate treatment on the level of serum cytokines including receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin among postmenopausal women with osteoporosis. The study group consisted of 61 postmenopausal women with osteoporosis. Patients were randomly divided in two groups: In group 1 (n = 41) postmenopausal women received oral risedronate (35 mg/week), calcium (1,000 mg/day), and vitamin D (400 IU/day) for 12 months. In group 2 (control group; n = 20) patients received only oral calcium (1,000 mg/day) and vitamin D (400 IU/day). Bone mineral density (BMD) of lumbar spine (L1-L4) and proximal femur were determined using dual X-ray absorptiometry at baseline and after one year. Venous blood samples were obtained for determination of serum cytokines including interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), RANKL, osteoprotegerin, and markers of bone formation and resorption. Levels of serum cytokines were measured before therapy and after three and 6 months. Markers of bone metabolism were studied before therapy and after 6 months. In group 1 (risedronate plus calcium/vitamin D-treated patients), serum levels of RANKL and IL-1beta significantly decreased and the level of osteoprotegerin significantly increased after three and 6 months, but no significant difference was found in TNF-alpha level. In group 2, however, the level of serum cytokines did not change after three and 6 months. In cases of bone turnover, both markers of bone resorption and formation significantly decreased after 6 months in group 1. In conclusion risedronate could improve osteoporosis by increasing osteoprotegerin and reducing RANKL and IL-1beta.


Subject(s)
Cytokines/blood , Etidronic Acid/analogs & derivatives , Osteoporosis, Postmenopausal/blood , Osteoporosis, Postmenopausal/drug therapy , Aged , Alkaline Phosphatase/blood , Bone Density/drug effects , Bone Density Conservation Agents/adverse effects , Bone Density Conservation Agents/pharmacology , Bone Density Conservation Agents/therapeutic use , Calcium/therapeutic use , Collagen Type I/blood , Etidronic Acid/adverse effects , Etidronic Acid/pharmacology , Etidronic Acid/therapeutic use , Female , Humans , Interleukin-1beta/blood , Middle Aged , Osteocalcin/blood , Osteoprotegerin/blood , Peptides/blood , RANK Ligand/blood , Risedronic Acid , Tumor Necrosis Factor-alpha/blood , Turkey , Vitamin D/therapeutic use
20.
Rheumatology (Oxford) ; 48(4): 433-5, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19223282

ABSTRACT

OBJECTIVE: To assess the prevalence of obstructive sleep apnoea syndrome (OSAS) in AS patients. METHODS: Thirty-one patients with AS were included in the study. The demographic data, spinal mobility measures and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores were recorded for each patient. All participants underwent one night of sleep recording, which was performed using a polysomnography (PSG). Pulmonary function test (PFT) was performed for all subjects and symptoms of OSAS were questioned. RESULTS: Seven (22.6%) of 31 AS patients had OSAS according to PSG assessments. The mean BMI, disease duration, BASDAI score, neck circumference and occiput-wall distance were higher in patients with OSAS, but the differences were not significant. The mean ages of patients with OSAS were significantly higher than the patients without OSAS. The prevalence of OSAS in patients under the age of 35 years was found to be 6.3%, whereas the prevalence of OSAS in patients at the age of 35 years or over was 40.0% (P = 0.037). The prevalence of OSAS in AS patients with a disease duration <5 years was 11.8% and its prevalence in AS patients with a disease duration of >or=5 years was 35.7% (P = 0.198). PFT was restrictive in 16 (53.3%) patients and obstructive in none. CONCLUSIONS: The prevalence of OSAS in AS patients is higher than reported in the general population. The diagnosis of OSAS should be kept in mind and OSAS symptoms should be considered especially in AS patients at the age of >or=35 years and in AS patients with a disease duration of >or=5 years.


Subject(s)
Sleep Apnea, Obstructive/complications , Spondylitis, Ankylosing/complications , Adult , Age Factors , Body Mass Index , Female , Humans , Lung/physiopathology , Male , Polysomnography , Prevalence , Respiratory Function Tests , Risk Factors , Sex Factors , Sleep Apnea, Obstructive/diagnosis , Sleep Apnea, Obstructive/physiopathology , Spondylitis, Ankylosing/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...